Akrivia Health
Generated by Meeveem AI
"Strategic partner in neuroscience data analytics for CNS and dementia drug development."
Oxford
•51 - 250 Employees
•Consulting
About Akrivia Health
Akrivia Health provides pharmaceutical and biotech companies with access to the largest validated real-world dataset in mental health and neuroscience. The company curates 6.3 million NHS patient records from 20+ trusts, spanning Alzheimer's disease, dementia, major depressive disorder, schizophrenia and neurological conditions. Through AI powered natural language processing, Akrivia transforms unstructured electronic health records into actionable insights. The dataset enables clinical development, early phase CNS drug discovery and rare disease programmes. Partners include pharmaceutical and biotech companies, CROs and genomic labs seeking longitudinal patient data to develop better treatments and accelerate therapy development.
55
Team Members
2019
Founded
Consulting
Sector
Hybrid
Work Environment
Our Vision
A world where comprehensive real-world mental health data accelerates neuroscience breakthroughs and transforms patient outcomes across dementia, depression and neurological disease.
Our Mission
Akrivia Health exists to transform mental health and dementia research by unlocking real-world patient data for pharmaceutical and biotech innovation.